← Open Payments lookup

HERU WANG: Open Payments

NPI 1124857768 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$568 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $692 · 2025 $568

Food & beverage: $568
CompanyPaymentsAmount
Lilly USA, LLC3$137
Gilead Sciences, Inc.1$109
Amgen Inc.2$51
Xeris Pharmaceuticals, Inc.2$46
Merck Sharp & Dohme LLC2$43
Otsuka America Pharmaceutical, Inc.2$42
Viatris Specialty LLC1$33
Boehringer Ingelheim Pharmaceuticals, Inc.1$28
VERTEX PHARMACEUTICALS INCORPORATED1$25
SANOFI PASTEUR INC.1$19

Products named: MOUNJARO, Vemlidy, TAVNEOS, GVOKE HYPOPEN, ROTATEQ, REXULTI, YUPELRI, OFEV.

Industry payments across CA — which companies pay providers there.